Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Starts Enrollment In Peripheral Lung Cancer Multi-Center Clinical Trial

Feb 22 (Reuters) - Mauna Kea Technologies SAS  MKEA.PA :
    * ANNOUNCES START OF ENROLLMENT IN PERIPHERAL LUNG CANCER
MULTI-CENTER CLINICAL TRIAL
    * THIS STUDY WILL INCLUDE UP TO 75 PATIENTS WITH PERIPHERAL
LUNG
NODULES IN AT LEAST 3 U.S. CENTERS

Source text for Eikon:  ID:nBw6Nln3na 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Mauna Kea Technologies SA

See all news